More than 4.5 million people suffer from psoriasis, which is a chronic skin disease that can cause patches of itchy, scaly, and inflamed skin. It is not a contagious disease. Although there isn't a cure for the disease, several treatments can keep it under control.
The FDA based its approval on studies that showed the skin cream significantly improved mild to severe cases of psoriasis.
Taclonex was developed in Denmark in 2001 and has been used in 63 countries under the names Dovobet and Daivobet.
Warner Chilcott will market Taclonex in the U.S. and expects to have the drug available in pharmacies by June 2006, the company says in a news release.